Asymmetric synthesis and absolute configuration assignment of a new type of bedaquiline analogue

Molecules

Volumn 20, Issue 12, 2015, Pages 22272-22285

  Qiao, Chang Jiang ^a,b   Wang, Xiao Kui ^b   Xie, Fei ^b   Zhong, Wu ^b   Li, Song ^a,b   Dehaen, Wim ^c  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE OF PHARMACOLOGY AND TOXICOLOGY   (China)

^c NONE

Author keywords

Absolute configuration assignment; Antituberculosis; Asymmetric synthesis; Bedaquiline analogues

Indexed keywords

BEDAQUILINE; NAPHTHALENE DERIVATIVE; QUINOLINE DERIVATIVE; TUBERCULOSTATIC AGENT;

CHEMISTRY; CIRCULAR DICHROISM; DRUG DESIGN; MOLECULAR MODEL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOISOMERISM; SYNTHESIS;

ANTITUBERCULAR AGENTS; CIRCULAR DICHROISM; DIARYLQUINOLINES; DRUG DESIGN; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; NAPHTHALENES; QUINOLINES; STEREOISOMERISM;

EID: 84954349926     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules201219846     Document Type: Article

References (33)

1. Keshavjee, S.; Farmer, P.E. Tuberculosis, drug resistance, and the history of modern medicine. N. Engl. J. Med. 2012, 367, 931-936.
2. Getahun, H.; Matteelli, A.; Chaisson, R.E.; Raviglione, M. Latent mycobacterium tuberculosis infection. N. Engl. J. Med. 2015, 372, 2127-2135.
3. Global Tuberculosis Report 2015. Available online: http://www.who.int/tb/publications/global-report/en/ (accessed on 8 December 2015).
4. Andries, K.; Verhasselt, P.; Guillemont, J.; Gohlmann, H.W.; Neefs, J.M.; Winkler, H.; Van Gestel, J.; Timmerman, P.; Zhu, M.; Lee, E.; et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005, 307, 223-227.
5. Koul, A.; Dendouga, N.; Vergauwen, K.; Molenberghs, B.; Vranckx, L.; Willebrords, R.; Ristic, Z.; Lill, H.; Dorange, I.; Guillemont, J.; et al. Diarylquinolines target subunit V of mycobacterial ATP synthase. Nat. Chem. Biol. 2007, 3, 323-324.
6. Haagsma, A.C.; Podasca, I.; Koul, A.; Andries, K.; Guillemont, J.; Lill, H.; Bald, D. Probing the interaction of the diarylquinoline TMC207 with its target mycobacterial ATP synthase. PLoS ONE 2011, 6, e23575.
7. De Jonge, M.R.; Koymans, L.H.; Guillemont, J.E.; Koul, A.; Andries, K. A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910. Proteins Struct. Funct. Bioinform. 2007, 67, 971-980.
8. Segala, E.; Sougakoff, W.; Nevejans-Chauffour, A.; Jarlier, V.; Petrella, S. New mutations in the mycobacterial atp synthase: New insights into the binding of the diarylquinoline TMC207 to the ATP synthase C-ring structure. Antimicrob. Agents Chemother. 2012, 56, 2326-2334.
9. Biukovic, G.; Basak, S.; Manimekalai, M.S.; Rishikesan, S.; Roessle, M.; Dick, T.; Rao, S.P.; Hunke, C.; Gruber, G. Variations of subunit ε of the Mycobacterium tuberculosis F1FO ATP synthase and a novel model for mechanism of action of the tuberculosis drug TMC207. Antimicrob. Agents Chemother. 2013, 57, 168-176.
10. Preiss, L.; Langer, J.D.; Yildiz, Ö.; Eckhardt-Strelau, L.; Guillemont, J.E.; Koul, A.; Meier, T. Structure of the mycobacterial ATP synthase of rotor ring in complex with the anti-TB drug bedaquiline. Sci. Adv. 2015, 1, e1500106.
11. Guillemont, J.; Meyer, C.; Poncelet, A.; Bourdrez, X.; Andries, K. Diarylquinolines, synthesis pathways and quantitative structure-activity relationship studies leading to the discovery of TMC207. Future Med. Chem. 2011, 3, 1345-1360.
12. Balemans, W.; Vranckx, L.; Lounis, N.; Pop, O.; Guillemont, J.; Vergauwen, K.; Mol, S.; Gilissen, R.; Motte, M.; Lancois, D.; et al. Novel antibiotics targeting respiratory ATP synthesis in Gram-positive pathogenic bacteria. Antimicrob. Agents Chemother. 2012, 56, 4131-4139.
13. Upadhayaya, R.S.; Kulkarni, G.M.; Vasireddy, N.R.; Vandavasi, J.K.; Dixit, S.S.; Sharma, V.; Chattopadhyaya, J. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis. Bioorg. Med. Chem. 2009, 17, 4681-4692.
14. Upadhayaya, R.S.; Vandavasi, J.K.; Vasireddy, N.R.; Sharma, V.; Dixit, S.S.; Chattopadhyaya, J. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis. Bioorg. Med. Chem. 2009, 17, 2830-2841.
15. Upadhayaya, R.S.; Lahore, S.V.; Sayyed, A.Y.; Dixit, S.S.; Shinde, P.D.; Chattopadhyaya, J. Conformationally-constrained indeno[2,1-c]quinolines - A new class of anti-mycobacterial agents. Org. Biomol. Chem. 2010, 8, 2180-2197.
16. Upadhayaya, R.S.; Shinde, P.D.; Sayyed, A.Y.; Kadam, S.A.; Bawane, A.N.; Poddar, A.; Plashkevych, O.; Foldesi, A.; Chattopadhyaya, J. Synthesis and structure of azole-fused indeno[2,1-c]quinolines and their anti-mycobacterial properties. Org. Biomol. Chem. 2010, 8, 5661-5673.
17. Upadhayaya, R.S.; Vandavasi, J.K.; Kardile, R.A.; Lahore, S.V.; Dixit, S.S.; Deokar, H.S.; Shinde, P.D.; Sarmah, M.P.; Chattopadhyaya, J. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents. Eur. J. Med. Chem. 2010, 45, 1854-1867.
18. Li, S.; Zhong, W.; Liu, P.; Xiao, J.; Zheng, Z.; Xie, Y.; Zhao, G.; Wang, X.; Wang, L.; Li, X. 2013. Aromatic butan-2-ol Compounds, Preparation Methods and Uses Thereof. U.S. Patent 8,674,136, 18 March 2014.
19. Saga, Y.; Motoki, R.; Makino, S.; Shimizu, Y.; Kanai, M.; Shibasaki, M. Catalytic asymmetric synthesis of R207910. J. Am. Chem. Soc. 2010, 132, 7905-7907.
20. Chandrasekhar, S.; Babu, G.S.K.; Mohapatra, D.K. Practical syntheses of (2S)-R207910 and (2R)-R207910. Eur. J. Org. Chem. 2011, 2011, 2057-2061.
21. Murphy, R.A.; Kung, H.F.; Kung, M.P.; Billings, J. Synthesis and characterization of iodobenzamide analogues: Potential D-2 dopamine receptor imaging agents. J. Med. Chem. 1990, 33, 171-178.
22. Gao, Y.; Klunder, J.M.; Hanson, R.M.; Masamune, H.; Ko, S.Y.; Sharpless, K.B. Catalytic asymmetric epoxidation and kinetic resolution: Modified procedures including in situ derivatization. J. Am. Chem. Soc. 1987, 109, 5765-5780.
23. Dieter, R.K.; Silks, L.A.; Fishpaugh, J.A.; Kastner, M.E. Control of chemo- and stereoselectivity in the reactions of organocuprates with α-oxoketene dithioacetals. J. Am. Chem. Soc. 1985, 107, 4679-4692.
24. Zhong, Y.L.; Shing, T.K.M. Efficient and facile glycol cleavage oxidation using improved silica gel-supported sodium metaperiodate. J. Org. Chem. 1997, 62, 2622-2624.
25. Zhang, Y.M.; Jia, X.F.; Wang, J.X. The solvent-free addition reaction of allylzinc bromide and carbonyl compounds. Eur. J. Org. Chem. 2009, 2983-2986.
26. Knochel, P.; Yeh, M.C.P.; Berk, S.C.; Talbert, J. Synthesis and reactivity toward acyl chlorides and enones of the new highly functionalized copper reagents RCu(CN)Zni. J. Org. Chem. 1988, 53, 2390-2392.
27. Pappo, R.; Allen, J.D.S.; Lemieux, R.U.; Johnson, W.S. Notes-Osmium tetroxide-catalyzed periodate oxidation of olefinic bonds. J. Org. Chem. 1956, 21, 478-479.
28. Katsuki, T.; Sharpless, K.B. The first practical method for asymmetric epoxidation. J. Am. Chem. Soc. 1980, 102, 5974-5976.
29. Pescitelli, G.; Di Bari, L.; Berova, N. Conformational aspects in the studies of organic compounds by electronic circular dichroism. Chem. Soc. Rev. 2011, 40, 4603-4625.
30. McCann, D.M.; Stephens, P.J. Determination of absolute configuration using density functional theory calculations of optical rotation and electronic circular dichroism: Chiral alkenes. J. Org. Chem. 2006, 71, 6074-6098.
31. 4. 1. Snatzke's method revisited. J. Org. Chem. 2001, 66, 4819-4825.
32. 4]. Tetrahedron 1981, 37, 349-361.
33. Gaurrand, S.; Desjardins, S.; Meyer, C.; Bonnet, P.; Argoullon, J.M.; Oulyadi, H.; Guillemont, J. Conformational analysis of R207910, a new drug candidate for the treatment of tuberculosis, by a combined NMR and molecular modeling approach. Chem. Biol. Drug Des. 2006, 68, 77-84.